Showing results (1771-1780 of 1,948) with videos related to
Sort By:
Pageof 195
Diagnostics (Basel, Switzerland)|May 11, 2024
Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and StagesBrittany A McKelvey, Hillary S Andrews, Frederick L Baehner, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 31, 2017
The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ TransplantationJ Levitsky, R N Formica, R D Bloom, et al.Cytotherapy|February 27, 2022
Need for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trialsMark D Stewart, Bruce McCall, Marcelo Pasquini, et al.The Journal of Hospital Infection|July 4, 2018
Development of consensus-based national antimicrobial stewardship competencies for UK undergraduate healthcare professional educationM Courtenay, R Lim, E Castro-Sanchez, et al.Mayo Clinic Proceedings. Digital Health|June 26, 2025
CF Tummy Tracker: A Cystic Fibrosis-Specific Patient-Reported Outcome Measure for Daily Gastrointestinal Symptom BurdenRebecca J Calthorpe, Hisham A Saumtally, Laura M Howells, et al.Nature Communications|April 28, 2025
Angiogenic and immune predictors of neoadjuvant axitinib response in renal cell carcinoma with venous tumour thrombusRebecca Wray, Hania Paverd, Ines Machado, et al.Nature Genetics|January 12, 2023
Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseasesYiheng Chen, Tianyuan Lu, Ulrika Pettersson-Kymmer, et al.Thorax|June 19, 2025
Basement membrane repair response biomarker PRO-C4 predicts progression in idiopathic pulmonary fibrosis: analysis of the PFBIO and PROFILE cohortsJannie M B Sand, Peder Frederiksen, Alison E John, et al.Bioorganic & Medicinal Chemistry Letters|June 9, 2006
1,4-Dihydroindeno[1,2-c]pyrazoles as novel multitargeted receptor tyrosine kinase inhibitorsJürgen Dinges, Kimba L Ashworth, Irini Akritopoulou-Zanze, et al.Cell|April 20, 2019
Human Gain-of-Function MC4R Variants Show Signaling Bias and Protect against ObesityLuca A Lotta, Jacek Mokrosiński, Edson Mendes de Oliveira, et al.Pageof 195